Markets

Insider Trading

Hedge Funds

Retirement

Opinion

5 Best Growth Stocks to Buy With Highest Upside Potential

In this piece we will look at the 5 Best Growth Stocks to Buy With Highest Upside Potential. Please visit 10 Best Growth Stocks to Buy With Highest Upside Potential if you’d like to see an extended list and how we came up with the list of Best Growth Stocks to Buy With Highest Upside Potential.

​5. ACM Research, Inc. (NASDAQ:ACMR)

Number of Hedge Fund Holders: 32

Analyst Upside Potential: 64.64%

​ACM Research, Inc. (NASDAQ:ACMR) is one of the Best Growth Stocks to Buy With Highest Upside Potential. On April 2, ACM Research, Inc. (NASDAQ:ACMR) announced a major rebranding and organization of the company’s product portfolio. The company is doing this by introducing the ACM Planetary Family, which is a themed structure grouping their tools into eight “planets” based on key steps in the chip-making process.

​Management noted that this move is aimed at simplifying the growing portfolio into a cleaner product lineup. CEO of the company, Dr. David Wang, highlighted that it is a strategic evolution to create a structured foundation for technological innovation, scalable product platforms, and global customer expansion.

​The eight planets breakdown includes Earth, Jupiter, Venus, Mars, Mercury, Saturn, Uranus, and Neptune series. Each series targets a core manufacturing step from cleaning tools to precise polishing.

​Overall, analysts have a bullish sentiment on ACM Research, Inc. (NASDAQ:ACMR) as 6 out of the 7 analysts covering the stock have maintained a Buy rating. Moreover, the average 12 month median price target on the stock suggests more than 64.6% upside from the current level.

​​ACM Research Inc. (NASDAQ:ACMR), together with its subsidiaries, develops, manufactures, and sells capital equipment in Mainland China and internationally. It also develops, manufactures, and sells a range of packaging tools to wafer assembly and packaging customers.

​4. Astera Labs, Inc. (NASDAQ:ALAB)

Number of Hedge Fund Holders: 52

Analyst Upside Potential: 72.28%

​Astera Labs, Inc. (NASDAQ:ALAB) is one of the Best Growth Stocks to Buy With Highest Upside Potential. On April 2, Citi lowered its price target on Astera Labs, Inc. (NASDAQ:ALAB) from $250 to $200, while maintaining a Buy rating on the stock. The firm cited that the reduced price target is due to the AI valuations. Moreover, Citi remains bullish on the company’s Scorpio opportunity and believes it remains intact. The firm also noted that Astera Labs stands to gain significantly from the expanding AI scale-up trend, positioning it as a prime beneficiary in AI infrastructure demand.

​The analysts explained in the research note that the shift to the PCIe switch business, especially the Scorpio family, will boost earnings significantly by 2028. Moreover, the co-packaged optics will complement rather than replace this core opportunity.

​Overall, the narrative around Astera Labs, Inc. (NASDAQ:ALAB) remains bullish as 78% of the 23 analysts covering the stock maintain a Buy rating. The average 12-month price target reflects more than 72% upside from the current level.

​Astera Labs, Inc. (NASDAQ:ALAB) provides high-performance connectivity solutions essential for AI data centers, including retimers, switches, and interconnect technologies. With increasing demand for efficient data movement in AI workloads, strong analyst support, and growing recognition as a core enabler of AI infrastructure, the company is well-positioned to deliver substantial long-term growth, supporting a high-upside investment thesis.

​3. Affirm Holdings, Inc. (NASDAQ:AFRM)

Number of Hedge Fund Holders: 63

Analyst Upside Potential: 75.11%

​Affirm Holdings, Inc. (NASDAQ:AFRM) is one of the Best Growth Stocks to Buy With Highest Upside Potential. The Street has a bullish sentiment on Affirm Holdings, Inc. (NASDAQ:AFRM) as 27 of the 34 analysts covering the stock maintain a Buy rating. Moreover, the analyst’s average 12-month price target suggests more than 75% upside from the current level.

​Recently, on March 31, TD Cowen lowered the firm’s price target on the stock from $95 to $80, while maintaining a Buy rating on the stock. The firm cited that they reduced price targets among the consumer finance group as part of their Q1 earnings preview. TD Cowen highlighted that the macro environment has created uncertainty among investors. Moreover, the AI’s impact on employment and the increased gas prices are also creating headwinds for low-income consumers. Despite lowering the price target, TD Cowen named Affirm as one of its top picks in the sector.

​Earlier on March 18, Mizuho had reiterated an Outperform rating on Affirm Holdings, Inc. (NASDAQ:AFRM) with a price target of $95. The firm addressed concerns from a Wall Street Journal report on Stone Ridge limiting redemptions on a fund holding Affirm loans. The firm highlighted strong investor demand for Affirm’s loans, noting an asset-backed securities (ABS) issuance was upsized from $500 million to $750 million. Mizuho emphasized Affirm’s short loan durations as an enabler of quick underwriting adjustments to macroeconomic or geopolitical shocks, alongside stable delinquency rates.

Affirm Holdings, Inc. (NASDAQ:AFRM) operates a payment network across Canada, the United States, and internationally. The company’s platform includes a consumer-focused app, a point-of-sale payment solution for consumers, and merchant commerce solutions. It offers BNPL loans, payment solutions, and financial services to consumers and merchants. It was incorporated in 2012 and is based in San Francisco, California.

​2. Ambarella, Inc. (NASDAQ:AMBA)

Number of Hedge Fund Holders: 37

Analyst Upside Potential: 81.41%

​Ambarella, Inc. (NASDAQ:AMBA) is one of the Best Growth Stocks to Buy With Highest Upside Potential. On March 30, Northland Securities released a research note saying that they have turned incrementally more positive on Ambarella, Inc. (NASDAQ:AMBA). The firm has a Buy rating on the stock with a price target of $101.

​The firm noted that the conflict between the US and Iran is expected to have a huge impact on the semiconductor industry and also highlighted that the AI algorithm demand is shifting from Memory to logic. The analysts also pointed out that the disrupted supply chain in Asia and reduced liquidity are also expected to impact AI infrastructure spending.

​That said, Ambarella, Inc. (NASDAQ:AMBA) had posted strong results in fiscal Q4 2026. The company grew its quarterly revenue by 20.06% year-over-year to $100.87 million and topped expectations by $700,380. The EPS of $0.13 also exceeded expectations by $0.03.

​Ambarella, Inc. (NASDAQ:AMBA) develops low-power system-on-a-chip, or SoC, semiconductors and software for edge artificial intelligence, or AI, applications.

​1. ADMA Biologics, Inc. (NASDAQ:ADMA)

Number of Hedge Fund Holders: 38

Analyst Upside Potential: 226.44%

ADMA Biologics, Inc. (NASDAQ:ADMA) is one of the Best Growth Stocks to Buy With Highest Upside Potential. On March 26, Cantor Fitzgerald analyst Kristen Kluska downgraded ADMA Biologics, Inc. (NASDAQ:ADMA) from Overweight to Neutral, without disclosing any price targets.

​The analyst said in a research note that the main reason behind the downgrade is dissatisfaction with ADMA’s response to allegations of channel stuffing to inflate Asceniv’s revenues. The analyst noted meeting with investors who are disappointed with the company’s lack of direct communication after the report. The firm sought more specific rebuttals to the claims but noted constraints from ADMA’s quiet period. Moreover, some other key financial red flags included rising days sales outstanding and accounts receivable, signaling potential revenue quality issues.

​The report discussed by Cantor Fitzgerald’s analyst in the research report was by Culper Research that alleged ADMA of boosting 2025 revenue by inducing distributors to stock excess Asceniv via rebates and extended terms, masking an underlying -3% decline.

​ADMA Biologics, Inc. (NASDAQ:ADMA) is a biopharmaceutical company that develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.

While we acknowledge the potential of ADMA to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than ADMA and that has 100x upside potential, check out our report about the cheapest AI stock.

READ NEXT: 7 Hot Growth Stocks to Invest in Right Now and 7 Ridiculously Cheap Stocks to Buy According to Wall Street Analysts. 

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s what to do next:

1. Subscribe to our Premium Readership Newsletter for just $9.99 a month. (33% Off – was $14.99).

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

<b>Cancel anytime.</b> Turn off auto-renewal via our website with just a click.

 

Buy This $3 Stock Now Before the 400% Surge Begins

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

My name is Inan Dogan. I’m the co-founder and Research Director of Insider Monkey. I have an important message for you today.

Since March 2017, my stock picks have returned 16.5% annually. Today, I’ve found an opportunity even bigger than my British American Tobacco call.

Two years ago, Wall Street wrote off British American Tobacco (BTI) as a “melting ice cube.” The stock had crashed 40% from its peak, and consensus said the business was dying.

We looked under the cover and realized they were wrong.

We alerted our subscribers, and BTI returned 90% in just 16 months.

Now if you had invested just $10,000 in BTI in June 2024, you’d be sitting on $19,000 in October 2025.

Today, we have identified a nearly identical pattern in a digital-first giant trading at $3.

While the market panics over a surface-level revenue decline, our PhD-led research shows management has actually surgically cut $100 million in waste to focus on high-margin growth.

This pattern is a hallmark of our 16.5% annual return track record. The current opportunity offers a 400% upside potential—dwarfing even our 90% BTI return.

Get the ticker for our new “Underdog” pick and the full BTI case study for just 99 cents.

This exclusive offer is for NEW newsletter subscribers ONLY! Join our Premium Readership Newsletter for only $0.99 and become part of a savvy investor community.!

This offer vanishes in 7 days, so don’t miss your chance to lock in market beating returnsSign up NOW! The monthly newsletter comes with a 30-day, no-risk money-back guarantee. This offer is available to the first 1000 new investors who respond.

Regular price $9.99/mo. Cancel anytime.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $0.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Regular price $9.99/mo. Cancel anytime.